Planta Med 2006; 72(5): 387-392
DOI: 10.1055/s-2005-916235
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Endophytic Fungal Metabolite Fumigaclavine C Causes Relaxation of Isolated Rat Aortic Rings

Hsiao-Yen Ma1 , Yong-Chun Song1 , Ying-Ying Mao1 , Ji-Hong Jiang2 , Ren-Xiang Tan1 , Lan Luo1
  • 1Institute of Functional Biomolecules, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, P. R. China
  • 2Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, Xuzhou Normal University, Xuzhou, P. R. China
Further Information

Publication History

Received: July 8, 2005

Accepted: September 22, 2005

Publication Date:
20 January 2006 (online)

Preview

Abstract

Two indole alkaloids were isolated from the culture of Aspergillus fumigatus (strain No. CY018), an endophytic fungus harboring inside the elder leaf of Cynodon dactylon. These two chemicals were identified as fumigaclavine C and fumitremorgin C. In screening the bioactivity of these two indole alkaloids, their vasorelaxant effects on isolated rat thoracic aortic rings were observed. The results showed that fumigaclavine C exhibited potent concentration-dependent vasorelaxant actions in isolated rat aortic rings pre-contracted by high K+ or phenylephrine (with EC50 values of 5.62 μmol/L and 1.58 μmol/L, respectively) whereas fumitremorgin C displayed a weaker vasorelaxation. A detailed investigation was therefore performed with fumigaclavine C. The vasorelaxing action of fumigaclavine C is independent of the presence of endothelium, suggesting its effect of vasorelaxation was not related to endothelial mediators. Blockage of L-type voltage-dependent calcium channels, activation of ATP-sensitive potassium channels and inhibition of Ca2+ release from intracellular Ca2+ stores may be involved in fumigaclavine C induced relaxation of rat isolated aortic rings. These results demonstrate that fumigaclavine C from the endophytic fungus has a potential capacity in vascular protection and thus may have therapeutic use in protection against cardiovascular disease.

References

Dr. Lan Luo

Institute of Functional Biomolecules

State Key Laboratory of Pharmaceutical Biotechnology

School of Life Sciences

Nanjing University

Nanjing 210093

People’s Republic of China

Phone: +86-25-8368-6657

Fax: +86-25-8359-2705

Email: lanluo@nju.edu.cn